您的位置: 首页 > 农业专利 > 详情页

VLP-BASED MONOVALENT EBOLA VACCINES AND METHODS OF MAKING AND USING SAME
专利权人:
Xuemin CHEN;Children's Hospital Medical Center
发明人:
Xuemin Chen,Karnail Singh,Paul Spearman
申请号:
US16494843
公开号:
US20200085937A1
申请日:
2018.03.28
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Disclosed herein are virus-like particle (VLP)-based monovalent vaccine compositions. The compositions may comprise a spherical retroviral Group-specific Antigen (“Gag”) protein core and a single Ebola glycoprotein selected from either a Zaire (EBOV) glycoprotein or a Sudan (SUDV) glycoprotein. The Ebola glycoprotein may be incorporated into the surface of the spherical Gag core, wherein said VLP-based vaccine presents a single Ebola glycoprotein antigen.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充